Delivery Order SPE2DB24D2100-SPE2DB24FBBRE

Award Date 5/24/24
Potential Completion Date 5/28/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award, valued at $1,947.96, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a period of performance through March 6, 2023. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract has a ceiling value of $1,617.27 and a completion date of June 17, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,122,284 units of the pharmaceutical product PRADAXA 75 MG CAPSULE UD 60S. The contract has a ceiling value of $1,196.76 and is a Firm-Fixed-Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,033.98 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,338.60 and is for the delivery of PRADAXA 150 MG CAPSULE UD 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. There is no set-aside designation for this contract, indicating it was open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,342.94, is for the delivery of PRADAXA 150MG 60S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,045.72 fixed-price delivery order is for the procurement of Pradaxa 150 mg capsules. The contract has an ultimate completion date of October 16, 2023 and was awarded on October 13, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,383.95 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE, a cardiovascular medication. The award has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S to the U.S. government. The contract, valued at $2,589.99, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to various federal agencies, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of May 29, 2024....
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBBRE
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, to provide PRADAXA 150 MG CAPSULE UU 60S to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price of $1,714.06 and an ultimate completion date of May 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/23/24, 4:39 PM